Bathroom Remodel Blind Spots Still Causing Delays and Overruns in 2026 Novato, United States - February 9, 2026 / ...
Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Treated With Cyclin-Dependent Kinase ...
Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q4 CY2025 results topping the market’s revenue ...
3h
Insulated Concrete Forms (ICF) and Traditional Wall Systems: Key Differences in Modern Construction
Each wall system brings specific characteristics to a project...Evaluating factors like structural demands, energy ...
Hackers resurrect 90s IRC tricks with SSHStalker, using old exploits to quietly compromise thousands of Linux servers ...
The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...
Quest Diagnostics , a leading provider of diagnostic information services, today announced the launch of a novel blood test that uses advanced flow cytometry methods to assess measurable residual ...
Medical Device Network on MSN
Quest launches flow cytometry MRD test for myeloma
Quest expects the new blood test will support response monitoring in clinical trials.
The successful clinical validation of AlloHeme represents a key milestone in CareDx's Transplant+ strategy, expanding the Company's precision medicine capabilities into cell therapy, hematology, and ...
Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...
Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results